Trials / Conditions / Severe Renal Impairment
Severe Renal Impairment
5 registered clinical trials studyying Severe Renal Impairment.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Functio NCT04119843 | Ascelia Pharma AB | Phase 3 |
| Completed | A Study to Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney Disease NCT03165071 | Idorsia Pharmaceuticals Ltd. | Phase 1 |
| Completed | Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Ch NCT02207088 | AbbVie | Phase 3 |
| Terminated | A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tol NCT01675973 | Gilead Sciences | Phase 1 |
| Completed | Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus NCT01043094 | Kowa Research Institute, Inc. | Phase 4 |